BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16464942)

  • 1. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
    Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.
    Scaglia PA; Martínez AS; Feigerlová E; Bezrodnik L; Gaillard MI; Di Giovanni D; Ballerini MG; Jasper HG; Heinrich JJ; Fang P; Domené HM; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2012 May; 97(5):E830-9. PubMed ID: 22419735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity.
    Varco-Merth B; Feigerlová E; Shinde U; Rosenfeld RG; Hwa V; Rotwein P
    Mol Endocrinol; 2013 Jan; 27(1):150-61. PubMed ID: 23160480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain.
    Weaver AM; Silva CM
    Mol Endocrinol; 2006 Oct; 20(10):2392-405. PubMed ID: 16772534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5b deficiency: lessons from STAT5b gene mutations.
    Hwa V; Nadeau K; Wit JM; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):61-75. PubMed ID: 21396575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.
    Vidarsdottir S; Walenkamp MJ; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; White S; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3482-5. PubMed ID: 16787985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues on molecular diagnosis of GH signaling defects.
    Feigerlova E; Hwa V; Derr MA; Rosenfeld RG
    Endocr Dev; 2013; 24():118-27. PubMed ID: 23392100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.
    Hwa V; Little B; Adiyaman P; Kofoed EM; Pratt KL; Ocal G; Berberoglu M; Rosenfeld RG
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4260-6. PubMed ID: 15827093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation.
    Walenkamp MJ; Vidarsdottir S; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    Eur J Endocrinol; 2007 Feb; 156(2):155-65. PubMed ID: 17287404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5B deficiency: Impacts on human growth and immunity.
    Hwa V
    Growth Horm IGF Res; 2016 Jun; 28():16-20. PubMed ID: 26703237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
    Yip SH; Eguchi R; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.
    Varco-Merth B; Rotwein P
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E847-55. PubMed ID: 25205818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.